8-KLeadership ChangesExhibits & Filings

Hewlett Packard Enterprise Co 8-K Report, Executive Changes (Sep 22, 2022)

Filed September 22, 2022For Securities:HPEHPE-PC

Summary

This 8-K filing from Hewlett Packard Enterprise Company (HPE) announced a key addition to its Board of Directors. Effective September 22, 2022, Regina E. Dugan was appointed as a director and a member of the Board's Technology Committee. Ms. Dugan brings extensive experience, currently serving as President and CEO of Wellcome Leap Inc., a non-profit focused on health innovation and discovery. Her appointment is expected to bring valuable technological and strategic insights to HPE's board, particularly given the company's focus on technology solutions and innovation. Ms. Dugan will receive compensation in line with the company's existing non-employee director compensation program, with pro-rata equity and cash retainers for her initial term. This move signals HPE's continued commitment to strengthening its governance and leveraging diverse expertise at the highest level of the organization.

Key Highlights

  • 1Appointment of Regina E. Dugan as a Director to the Board, effective September 22, 2022.
  • 2Ms. Dugan also appointed to the Board's Technology Committee.
  • 3Ms. Dugan's current role as President and CEO of Wellcome Leap Inc. brings expertise in innovation and discovery.
  • 4Director compensation for Ms. Dugan will follow the standard non-employee director compensation program.
  • 5No family relationship or disclosable transactions exist between Ms. Dugan and HPE's executives or directors.
  • 6The filing includes a press release as an exhibit announcing these board changes.

Frequently Asked Questions

Regina E. Dugan is the President and CEO of Wellcome Leap Inc., a U.S. non-profit organization focused on accelerating discovery and innovation for human health. Her appointment to the HPE Board suggests a valuable external perspective on technology and innovation.

Her membership on the Technology Committee indicates that HPE values her expertise in technological advancements and strategic innovation, which is crucial for a company in the technology sector. This committee typically oversees technology strategy, research and development, and related investments.

Ms. Dugan will receive pro-rata portions of the annual equity and cash retainers provided under HPE's existing non-employee director compensation program for the remainder of the current board year. Thereafter, she will participate fully in this program.

The filing explicitly states that Ms. Dugan has no family relationships with any executive officers or directors of HPE and is not involved in any transactions requiring disclosure under Item 404(a) of Regulation S-K, indicating no apparent conflicts of interest.